Skip to main content
GutCited

Saccharomyces boulardii cho Antibiotic-Associated Diarrhea (AAD)

A

Multiple meta-analyses show S. boulardii reduces AAD risk by 47-53% (RR 0.47). Most studied probiotic for AAD prevention with consistent positive results across antibiotic classes.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dsaccharomyces\u002Dboulardii\u0026condition\u003Dantibiotic\u002Dassociated\u002Ddiarrhea'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Kết luận

Multiple meta-analyses show S. boulardii reduces AAD risk by 47-53% (RR 0.47). Most studied probiotic for AAD prevention with consistent positive results across antibiotic classes.

Key Study Findings

Observational Study n=279
Use of Probiotics During Antibiotic Therapy in Pediatrics: A Cross-Sectional Survey of Italian Primary Care …
Dose: None so với: None Outcome: Probiotic prescribing habits of Italian PCPs Hiệu quả: L. rhamnosus GG used by 91.8% None

Đối tượng nghiên cứu: Italian primary care pediatricians

Review
The evidence for probiotics in the treatment of digestive disorders in the pediatric population.
Dose: None so với: None Outcome: None Hiệu quả: None None

Đối tượng nghiên cứu: Pediatric population

Review
Intestinal Dysbiosis: Exploring Definition, Associated Symptoms, and Perspectives for a Comprehensive Understanding - a Scoping …
Dose: None so với: None Outcome: None Hiệu quả: None None

Đối tượng nghiên cứu: scoping review of intestinal dysbiosis definition, symptoms, and probiotic adjuvant therapy in adults and children

Other
Ibero-Latin American clinical practice guideline for the use of biotics in pediatric gastroenterology, hepatology, and …
Dose: None so với: None Outcome: Clinical guideline recommendations for pediatric GI Hiệu quả: None None

Đối tượng nghiên cứu: Pediatric patients with GI disorders

Review
Clostridioides difficile Infections: Prevention and Treatment Strategies.
Dose: None so với: None Outcome: C. difficile infection treatment outcomes Hiệu quả: None None

Đối tượng nghiên cứu: Patients with C. difficile infection

Randomized Controlled Trial n=47 1 weeks
[A prospective randomized controlled study on probiotics for the prevention of antibiotic-associated diarrhea in infants …
Dose: None so với: Control Outcome: Gut microbiota composition Hiệu quả: None P<0.017

Đối tượng nghiên cứu: Children

Key Statistics

25

Nghiên cứu

5000

Người tham gia

Positive

A

Xếp hạng

Referenced Papers

Advances in experimental … 2024 2 trích dẫn
Archivos argentinos de … 2022 23 trích dẫn
Advances in experimental … 2019 17 trích dẫn
The American journal … 2018 46 trích dẫn
Journal of pediatric … 2016 233 trích dẫn
Clinical and experimental … 2016 82 trích dẫn
Digestive diseases (Basel, … 2016 37 trích dẫn
The Cochrane database … 2015 233 trích dẫn
Journal of clinical … 2015 35 trích dẫn
Expert opinion on … 2014 57 trích dẫn
Journal of clinical … 2011 432 trích dẫn
World journal of … 2010 512 trích dẫn
Journal for specialists … 2010 22 trích dẫn
American journal of … 2010
European journal of … 2009 91 trích dẫn
Current opinion in … 2009 82 trích dẫn
Advances in biochemical … 2008 535 trích dẫn
American family physician 2008
The Journal of … 2007 265 trích dẫn
The American journal … 2001 648 trích dẫn
International journal of … 2000 181 trích dẫn
Clinical infectious diseases … 1998 346 trích dẫn

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Liều lượng thường dùng

general:
250-500 mg/day (equivalent to 5-10 billion CFU)
aadprevention:
500 mg/day (start with antibiotic, continue 7 days after)
cdiffprevention:
500 mg twice daily as adjunct to standard therapy
travelersdiarrhea:
250-500 mg/day starting 5 days before travel

Giới hạn trên: Well-tolerated up to 1,000 mg/day in clinical trials

Liều lượng đã nghiên cứu

Liều lượng Thời gian Hiệu quả N
None -- Mixed 279
None -- Mixed --
None -- Positive --
None -- Positive --
None -- Positive --
None 1 weeks Positive 47
None 20 weeks Positive 564
None -- Positive --

Thời điểm dùng tốt nhất: Can be taken with or without food; space 2 hours from antifungals

Safety & Side Effects

Tác dụng phụ đã được báo cáo

  • Mild gas and bloating
  • Rare: fungemia in critically ill patients with central venous catheters
  • Thirst (yeast may increase water requirements)
  • Very rare: potential environmental contamination risk in ICU settings

Tương tác đã biết

  • Antifungal medications (may kill S. boulardii, reducing effectiveness)
  • Monoamine oxidase inhibitors (S. boulardii contains tyramine)
  • Immunosuppressants (theoretical risk of fungemia in immunocompromised patients)

Mức hấp thụ tối đa cho phép: Well-tolerated up to 1,000 mg/day in clinical trials

Luôn tham khảo ý kiến bác sĩ trước khi bắt đầu sử dụng bất kỳ thực phẩm bổ sung nào.Luôn tham khảo ý kiến chuyên gia y tế trước khi sử dụng bất kỳ thực phẩm chức năng nào.

Frequently Asked Questions

Does Saccharomyces boulardii help with Antibiotic-Associated Diarrhea (AAD)?
Based on 25 studies with 5,000 participants, there is strong evidence from multiple clinical trials that Saccharomyces boulardii may support Antibiotic-Associated Diarrhea (AAD) management. Our evidence grade is A (Strong Evidence).
How much Saccharomyces boulardii should I take for Antibiotic-Associated Diarrhea (AAD)?
Studies have used various dosages. A commonly studied range is 250-500 mg/day (equivalent to 5-10 billion CFU). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Saccharomyces boulardii?
Reported side effects may include Mild gas and bloating, Rare: fungemia in critically ill patients with central venous catheters, Thirst (yeast may increase water requirements), Very rare: potential environmental contamination risk in ICU settings. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Saccharomyces boulardii and Antibiotic-Associated Diarrhea (AAD)?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 25 peer-reviewed studies with 5,000 total participants. The overall direction of effect is positive.

Related Evidence

Các thành phần khác cho Antibiotic-Associated Diarrhea (AAD)

Saccharomyces boulardii cho các tình trạng khác

Tuyên bố miễn trừ FDA: Các tuyên bố này chưa được Cục Quản lý Thực phẩm và Dược phẩm (FDA) đánh giá. Các sản phẩm và thông tin trên trang web này không nhằm mục đích chẩn đoán, điều trị, chữa bệnh hoặc phòng ngừa bất kỳ bệnh nào. Xếp hạng bằng chứng được trình bày dựa trên phân tích của chúng tôi về nghiên cứu đã bình duyệt được công bố và không cấu thành tư vấn y khoa. Luôn tham khảo ý kiến chuyên gia y tế trước khi bắt đầu bất kỳ chế độ thực phẩm chức năng nào.